Ron McElmurry

2.6k total citations
32 papers, 1.5k citations indexed

About

Ron McElmurry is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ron McElmurry has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Immunology and 7 papers in Oncology. Recurrent topics in Ron McElmurry's work include Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (6 papers) and RNA Interference and Gene Delivery (6 papers). Ron McElmurry is often cited by papers focused on Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (6 papers) and RNA Interference and Gene Delivery (6 papers). Ron McElmurry collaborates with scholars based in United States, United Kingdom and Japan. Ron McElmurry's co-authors include Bruce R. Blazar, Jakub Tolar, Mark J. Osborn, Jeffrey S. Miller, Angela Panoskaltsis‐Mortari, Martin Felices, Alexander J. Lenvik, Megan Riddle, Daniel A. Vallera and Lily Xia and has published in prestigious journals such as Blood, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

Ron McElmurry

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron McElmurry United States 18 634 494 492 267 194 32 1.5k
Elizabeth Clayton United Kingdom 13 490 0.8× 849 1.7× 357 0.7× 297 1.1× 103 0.5× 22 1.9k
Philip E. Lapinski United States 24 339 0.5× 897 1.8× 500 1.0× 183 0.7× 82 0.4× 40 1.7k
Friederike Pausch Germany 16 311 0.5× 877 1.8× 220 0.4× 328 1.2× 155 0.8× 19 2.0k
Pierre Vaigot France 22 361 0.6× 841 1.7× 301 0.6× 517 1.9× 99 0.5× 51 1.7k
Giorgia Salvagiotto United States 11 615 1.0× 1.0k 2.0× 192 0.4× 151 0.6× 110 0.6× 14 1.5k
Irène Rappold Germany 16 527 0.8× 840 1.7× 399 0.8× 159 0.6× 82 0.4× 18 1.7k
Judith A. Shizuru United States 8 583 0.9× 578 1.2× 255 0.5× 109 0.4× 174 0.9× 10 1.5k
Hideo Oshima Japan 15 910 1.4× 1.0k 2.0× 406 0.8× 850 3.2× 139 0.7× 26 2.9k
Helen Priddle United Kingdom 16 461 0.7× 1.2k 2.5× 180 0.4× 270 1.0× 185 1.0× 22 1.9k
Gregory W. Henkel United States 7 778 1.2× 885 1.8× 273 0.6× 142 0.5× 117 0.6× 8 1.7k

Countries citing papers authored by Ron McElmurry

Since Specialization
Citations

This map shows the geographic impact of Ron McElmurry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron McElmurry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron McElmurry more than expected).

Fields of papers citing papers by Ron McElmurry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron McElmurry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron McElmurry. The network helps show where Ron McElmurry may publish in the future.

Co-authorship network of co-authors of Ron McElmurry

This figure shows the co-authorship network connecting the top 25 collaborators of Ron McElmurry. A scholar is included among the top collaborators of Ron McElmurry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron McElmurry. Ron McElmurry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braunlin, Elizabeth, Juan E. Abrahante, Ron McElmurry, et al.. (2022). Contribution of the innate and adaptive immune systems to aortic dilation in murine mucopolysaccharidosis type I. Molecular Genetics and Metabolism. 135(3). 193–205. 3 indexed citations
2.
Felices, Martin, Todd Lenvik, Behiye Kodal, et al.. (2020). Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager. Cancer Immunology Research. 8(9). 1139–1149. 51 indexed citations
3.
Felices, Martin, Alexander J. Lenvik, Ron McElmurry, et al.. (2018). Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect. JCI Insight. 3(3). 184 indexed citations
4.
Webber, Beau R., Ron McElmurry, Cindy Eide, et al.. (2017). Rapid generation of Col7a1−/− mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells. Laboratory Investigation. 97(10). 1218–1224. 29 indexed citations
5.
Vallera, Daniel A., Martin Felices, Ron McElmurry, et al.. (2016). IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clinical Cancer Research. 22(14). 3440–3450. 295 indexed citations
6.
Felices, Martin, Alexander J. Lenvik, Sami Chu, et al.. (2016). Continuous IL-15 Signaling Leads to Functional Exhaustion of Human Natural Killer Cells through Metabolic Changes That Alters Their In Vivo Anti-Tumor Activity. Blood. 128(22). 551–551. 5 indexed citations
7.
Mathews, Wendy, et al.. (2016). miR-29 Regulates Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology. 136(10). 2013–2021. 19 indexed citations
8.
Webber, Beau R., Mark J. Osborn, Amber McElroy, et al.. (2016). CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa. npj Regenerative Medicine. 1(1). 80 indexed citations
9.
Felices, Martin, Daniel A. Vallera, Ron McElmurry, et al.. (2016). CD16-IL15-CD33 Trispecific Killer Engager (TriKE) induces NK cell expansion, persistence, and myeloid blast antigen specific killing.. The Journal of Immunology. 196(1_Supplement). 75.8–75.8.
10.
11.
Modiano, Jaime F., Ron McElmurry, Colleen L. Forster, et al.. (2015). Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment. Cancer Immunology Immunotherapy. 64(11). 1449–1460. 6 indexed citations
12.
Miller, Jeffrey S., Cliona M. Rooney, Julie Curtsinger, et al.. (2014). Expansion and Homing of Adoptively Transferred Human Natural Killer Cells in Immunodeficient Mice Varies with Product Preparation and In Vivo Cytokine Administration: Implications for Clinical Therapy. Biology of Blood and Marrow Transplantation. 20(8). 1252–1257. 64 indexed citations
13.
Tolar, Jakub, Lily Xia, Megan Riddle, et al.. (2010). Induced Pluripotent Stem Cells from Individuals with Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology. 131(4). 848–856. 118 indexed citations
14.
Osborn, Mark J., Ron McElmurry, Christopher J. Lees, et al.. (2010). Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-L-Iduronidase in Mice With Mucopolysaccharidosis Type I. Molecular Therapy. 19(3). 450–460. 77 indexed citations
15.
Tolar, Jakub, Akemi Ishida‐Yamamoto, Megan Riddle, et al.. (2008). Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood. 113(5). 1167–1174. 125 indexed citations
16.
Osborn, Mark J., et al.. (2008). Targeting of the CNS in MPS-IH Using a Nonviral Transferrin-α-l-iduronidase Fusion Gene Product. Molecular Therapy. 16(8). 1459–1466. 39 indexed citations
17.
Tolar, Jakub, Xiaohong Wang, Elizabeth Braunlin, et al.. (2007). The host immune response is essential for the beneficial effect of adult stem cells after myocardial ischemia. Experimental Hematology. 35(4). 682–690. 9 indexed citations
18.
Osborn, Mark J., Angela Panoskaltsis‐Mortari, Ron McElmurry, et al.. (2005). A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system. Molecular Therapy. 12(3). 569–574. 53 indexed citations
19.
Tolar, Jakub, Mark J. Osborn, Scott Bell, et al.. (2005). Real-Time in Vivo Imaging of Stem Cells Following Transgenesis by Transposition. Molecular Therapy. 12(1). 42–48. 25 indexed citations
20.
Braunlin, Elizabeth, Shannon Mackey‐Bojack, Angela Panoskaltsis‐Mortari, et al.. (2005). Cardiac Functional and Histopathologic Findings in Humans and Mice with Mucopolysaccharidosis Type I: Implications for Assessment of Therapeutic Interventions in Hurler Syndrome. Pediatric Research. 59(1). 27–32. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Clayton Breakdown of academic impact, for papers by Philip E. Lapinski Breakdown of academic impact, for papers by Friederike Pausch Breakdown of academic impact, for papers by Pierre Vaigot Breakdown of academic impact, for papers by Giorgia Salvagiotto Breakdown of academic impact, for papers by Irène Rappold Breakdown of academic impact, for papers by Judith A. Shizuru Breakdown of academic impact, for papers by Hideo Oshima Breakdown of academic impact, for papers by Helen Priddle Breakdown of academic impact, for papers by Gregory W. Henkel
Rankless by CCL
2026